The Australian Melanoma Genome Project
Using whole genome sequencing technologies to identify the genetic mutations that cause melanoma, so treatment can be personalised.
Predicting response to immunotherapy
Identifying genes which determine response to immunotherapy, and then determining the signalling pathways these genes are affecting.
Adjuvant Therapy Clinical Trial
MIA is experiencing great success with multi-discipline trials in the neo-adjuvant and adjuvant settings.
Olympians join forces for melanoma warning
Jana Pittman and Melinda Gainsford-Taylor back our Game On Mole campaign, in support of their much loved coach.
Surgery Support Clinic
Research to determine the value of providing patients with the services of a support clinic following dissection surgery.
Patterns of Care Study
An observational study to determine best practice based on clinicians’ reported management of NSW melanoma patients over a 12-month period.
Saving our next generation
Searching for early-detection genetic markers and treatment options for 20 to 39 year olds.
MIA research wins Cancer Institute of NSW ‘Wildfire Highly Cited Publication’
Cited an incredible 427 times around the world, showing its vital role in improving outcomes for people with advanced melanoma.
Prof Scolyer receives UTAS Alumni Award
The 'Distinguished Alumni Award' from University of Tasmania honours the exceptional impact of his work around the world.
Medical Directors receive USYD VC’s Award
The 'Outstanding Research Award' recognises their life-saving discoveries transforming melanoma patient care.